Sunshine Biopharma, Inc.
SBFM
$1.40
-$0.02-1.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.31M | -5.03M | -5.13M | -4.23M | -3.68M |
| Total Depreciation and Amortization | 267.30K | 245.70K | 223.50K | 200.50K | 173.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06M | 0.00 | 12.00K | 12.40K | 12.00K |
| Change in Net Operating Assets | -2.78M | -6.28M | -7.63M | -7.80M | -7.42M |
| Cash from Operations | -7.76M | -11.06M | -12.53M | -11.81M | -10.91M |
| Capital Expenditure | -787.10K | -1.60M | -1.66M | -1.17M | -664.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -990.60K | -226.50K | -663.80K | -886.50K | -796.60K |
| Cash from Investing | -1.78M | -1.83M | -2.32M | -2.06M | -1.46M |
| Total Debt Issued | 347.90K | 347.90K | 347.90K | -- | -- |
| Total Debt Repaid | -17.40K | 12.40K | 0.00 | -120.80K | -120.40K |
| Issuance of Common Stock | 7.54M | 3.87M | 12.08M | 10.47M | 8.57M |
| Repurchase of Common Stock | 0.00 | 0.00 | -3.14M | -3.14M | -3.17M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.87M | 4.23M | 9.29M | 7.21M | 5.28M |
| Foreign Exchange rate Adjustments | 462.50K | -651.10K | -1.04M | 27.60K | -1.13M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -1.20M | -9.31M | -6.61M | -6.64M | -8.22M |